Caribou Biosciences, Inc.

CRBU · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 97 employees
102
SEC Filings
$2.32
Close 2026-06-02
97
Employees

Business Summary

PART I . Overview We are a clinical-stage C lustered R egularly I nterspaced S hort P alindromic R epeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our genome-editing platform is based on our novel chRDNA ( C RISPR h ybrid R NA- DNA , or chRDNA, pronounced chardonnay) genome-editing technology, which enables more precise genome editing of allogeneic cell therapies. Our allogeneic, or off-the-shelf, c...

Latest Stock Quote

CRBU 2026-06-02 $2.32 O:$2.45 H:$2.45 L:$2.29 Vol:1.7M VWAP:$2.3488
origin leaf: 9f8583de79fe684260f137633150d5de27f1985c72fe264086a6441d296640b3

Next Earnings

Q2 FY2026 — expected 2026-08-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001619856-26-000008EDGAR107K words
2025-03-102024-12-310001619856-25-000015EDGAR—
2024-03-112023-12-310001619856-24-000013EDGAR—
2023-03-092022-12-310001619856-23-000037EDGAR—
2022-03-212021-12-310000950170-22-004233EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001619856-25-000071EDGAR22K words
2025-08-122025-06-300001619856-25-000061EDGAR—
2025-05-082025-03-310001619856-25-000043EDGAR—
2024-11-062024-09-300001619856-24-000081EDGAR—
2024-08-062024-06-300001619856-24-000064EDGAR—
2024-05-072024-03-310001619856-24-000038EDGAR—
2023-11-072023-09-300001619856-23-000124EDGAR—
2023-08-082023-06-300001619856-23-000107EDGAR—
2023-05-092023-03-310001619856-23-000071EDGAR—
2022-11-082022-09-300001619856-22-000022EDGAR—
2022-08-092022-06-300000950170-22-016053EDGAR—
2022-05-092022-03-310000950170-22-008513EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001619856-26-000012EDGAR1K words
2026-03-050001619856-26-000007EDGAR—
2025-11-120001619856-25-000070EDGAR—
2025-11-030001619856-25-000065EDGAR—
2025-08-120001619856-25-000060EDGAR—
2025-06-230001619856-25-000052EDGAR—
2025-06-130001619856-25-000047EDGAR—
2025-05-080001619856-25-000040EDGAR—
2025-04-240001619856-25-000023EDGAR—
2025-03-100001619856-25-000014EDGAR—

102 total filings indexed. 75 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001619856
TickerCRBU
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.cariboubio.com
Listed2021-07-23

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c0614135c4e79d3738ab7d6c356ed6aa8a69f2eb06bfae2ee436742e662e5a09
parent: ea08c5f02c56859ffd0a7336a596480842e92291a681958df76acc52bb79bb30
content hash: afa41187bbf49d05b45c92783f5d12d77515de2eb55fe867a3756e416db36fbe
signed: 2026-06-03T12:00:44.164Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf